Cotellic
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.cotellic.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Cotellic
Cotellic is designed to inhibit MEK1/2, proteins in a cell signaling pathway that helps control cell growth and survival. Cotellic, when used in combination with Zelboraf, is approved in the United States and Europe, as well as many countries around the world, for the treatment of people with melanoma that has spread to other parts of the body or cannot be removed by surgery and has a BRAF V600 mutation. Cotellic was discovered by Exelixis and is being developed by Genentech, a member of the Roche Group, in collaboration with Exelixis.Explore more
Popular SearchesCotellicGenentech IncSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cotellic your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Cotellic has new funding data
Check out if Cotellic is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Cotellic
Click to see if Cotellic had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Cotellic, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Cotellic has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Cotellic recently announced quarterly report
Product Launch: Get notified when Cotellic launches new products
Recommended Actions
Find VP level buyers at Cotellic
Find more new buyers
Compare Similar Companies to Cotellic
Compare insights from companies similar to Cotellic, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Company Profile Activity
Activity Insights
Cotellic is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cotellic is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cotellic.
Cotellic Tech Stack
A closer look at the technologies used by Cotellic
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cotellic
Sign Up For FreeTo access detailed company insights
Cotellic is designed to inhibit MEK1/2, proteins in a cell signaling pathway that helps control cell growth and survival. Cotellic, when used in combination with Zelboraf, is approved in the United States and Europe, as well as many countries around the world, for the treatment of people with melanoma that has spread to other parts of the body or c... Read More
